Peripheral nerve stimulation (PNS) has evolved from niche use to an evidence‑supported option for chronic, focal pain. While the concept—using gentle electrical pulses to modulate peripheral nerves—is straightforward, the science and clinical guidance behind it have advanced rapidly. For clinicians, the question is no longer “Does PNS work?” but rather “Where does it fit in my practice, and how do I apply it effectively?”

How PNS Works: The Science Behind the Relief

Mechanistically, PNS reduces pain by influencing how signals travel from the periphery to the brain. The classic gate control model helps explain why stimulating large, low‑threshold fibers can dampen nociceptive transmission in the dorsal horn. Chemical changes add another layer: studies point to shifts in neurotransmitters such as GABA and serotonin, along with reduced inflammatory mediators. Over time, this peripheral input may help “recondition” central pathways, easing sensitization and improving the durability of relief beyond the stimulation period.

The Evidence: What the Trials Actually Show

The evidence base is strong and growing:

• COMFORT and COMFORT 2 trials: High responder rates (patients achieving at least 50% pain relief) with meaningful average pain reductions sustained at three to six months across common targets like shoulder, low back, knee, and foot/ankle.
• Large real‑world cohorts: Over 6,000 patients across dozens of nerve targets show clinically significant benefit beyond tightly controlled study settings.
• Bottom line: Level 1, guideline‑concordant support for appropriate patients.

Clinical Application: Target Selection and Technique

Translating evidence into practice hinges on target selection, imaging, and technique. PNS is most effective when the pain generator is focal and mappable to a specific nerve or branch. Common targets include:

• Medial branch nerves (multifidus support) for certain low back pain phenotypes
• Cluneal nerves for iliolumbar distributions
• Axillary or suprascapular for shoulder pain
• Genicular or saphenous for knee pain
• Select nerves for ankle and foot pain

Imaging matters: Ultrasound offers direct visualization of nerves and adjacent vasculature for many upper and lower extremity targets; fluoroscopy is valuable when landmarks are consistent, such as along the spine or near joints. Practical considerations—maintaining adequate lead length, avoiding paths that cross large, mobile joints, confirming sensory or motor responses prior to securing—help reduce migration and revisions.

Programming: Matching Settings to Goals

Programming should match intent:

• Low frequency: Useful when therapeutic muscle activation supports function (for example, multifidus engagement).
• Mid‑range: Commonly used for analgesia and often present as mild paresthesia.
• High frequency: Paresthesia‑independent approaches are promising and under active investigation.

Across all approaches, consistency and individualized titration drive outcomes.

Beyond Pain: Expanding Applications

PNS is also expanding beyond pain management. Evidence supports neuromodulatory roles in sleep and respiration (hypoglossal for obstructive sleep apnea; phrenic for central sleep apnea), pelvic floor dysfunction (posterior tibial nerve stimulation for bowel and bladder indications), and movement disorders (common peroneal stimulation for restless legs syndrome). While indications and strength of evidence vary, the clinical horizon is broadening.

Coverage, Coding, and Value

Access and implementation still matter. Medicare recognizes coverage for PNS, and local policies detail criteria; Medicare Advantage plans are expected to align with these standards, though appeals may be required. Coding accuracy—distinguishing integrated versus non‑integrated systems and understanding when ultrasound guidance is separately billable—helps prevent denials. Notably, routine psychological screening has limited evidence as a predictor of PNS success and may be reconsidered as a blanket requirement.

Finally, PNS aligns with value‑based aims. Studies report reductions in office visits, procedures, imaging, emergency and hospital utilization, along with decreased opioid use and overall costs. Clinically, standardizing education and expectations can streamline consent and follow‑up, giving teams time back without sacrificing patient understanding.

The Takeaway

In short, PNS is a targeted, evidence‑backed modality that fits real‑world care. With careful selection, image‑guided placement, and thoughtful programming, it can deliver durable relief while supporting efficiency and patient trust.

For full details, evidence tables, and procedural guidance, read the complete article: Consensus Guidelines for the Use of Peripheral Nerve Stimulation in the Treatment of Chronic Pain and Neurological Diseases: A Neuron Project from the American Society of Pain and Neuroscience